This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
NG2 cells in Huntingtons disease Investments < €500k United States of America 2016
Investigating the contributions of astrocyte gap junctions to ALS disease progression Investments < €500k United States of America 2016
Cellular mechanisms underlying detoxification of mutant Huntingtin Investments < €500k United States of America 2016
Gene Therapy for Upper Airway and Respiratory Insufficiency in an ALS Mouse Model Investments < €500k United States of America 2016
Genome editing in HD iPS cells to reduce mutant and total Huntington expression Investments < €500k United States of America 2016
Mitochondrial SIRT3 in Huntingtons disease Investments < €500k United States of America 2016
Neuroprotection by MC1R as the basis for the melanoma-Parkinsons disease link Investments < €500k United States of America 2016
Design and development of a mixed reality system for skilled locomotor training in individuals with Parkinsons disease Investments < €500k United States of America 2016
Roles of heat shock protein 110 in modulating amyloid neurotoxicity Investments < €500k United States of America 2016
Genetic Susceptibility to Manganese Neurotoxicity Investments < €500k United States of America 2016
